RFG Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
RFG Advisory's REGN Position: Q2 2026 in Review
RFG Advisory reduced its Regeneron Pharmaceuticals (REGN) stake by 43% in Q2 2026, selling an estimated $400K and leaving 789 shares worth $492K. The position accounts for 0.01% of the portfolio, ranked #787.
RFG Advisory first reported a position in REGN in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.06M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- RFG Advisory held 789 shares of Regeneron Pharmaceuticals worth $492K as of Q2 2026.
- RFG Advisory sold 587 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $400K.
- Regeneron Pharmaceuticals made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #787 holding.
- RFG Advisory first reported a position in Regeneron Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- RFG Advisory's Regeneron Pharmaceuticals position peaked at $1.06M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.